Nyxoah Names Scott Holstine Chief Commercial Officer

Nyxoah (NYXH) said Monday it named Scott Holstine as chief commercial officer.Holstine has more than 26 years of experience and specializes in US product launches, the company said.Shares of the

MT NewswiresJul 15 03:42 ET

Express News | Nyxoah Announced That It Has Signed a €37.5M Loan Facility Agreement With the European Investment Bank

BenzingaJul 3 06:31 ET

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement With the European Investment Bank

REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA

GlobeNewswireJul 3 06:30 ET

Nyxoah Submits Final Module of Premarket Approval Application for Sleep Apnea Therapy to FDA

Nyxoah (NYXH) said Monday it has submitted the final module of its premarket approval application for its Genio sleep apnea therapy to the US Food and Drug Administration. Genio is a hypoglossal nerve

MT NewswiresJul 1 11:21 ET

H.C. Wainwright Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $18

H.C. Wainwright analyst Edward White maintains $Nyxoah SA(NYXH.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate of 28.1% and a t

Moomoo NewsJul 1 10:32 ET · Ratings

Nyxoah Submits Final Module for FDA Approval of Innovative Sleep Apnea Treatment

"Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Compa

BenzingaJul 1 02:52 ET